Roslin, United Kingdom · Founded 2013 · Privately Held (backing)
Operator of a biotechnology company intended for medical research, disease modeling, and drug development. Axol Bioscience is based in Roslin, United Kingdom and was founded in 2013. Its last reported valuation was $128 million in Aug 2017. It has raised $19.9 million.
Last reported valuation
$128.1M
Oct 2026
Priced at
—
Total raised
$19.9M
Last round
—
Team — not yet on record
No current team members for Axol Bioscience are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Axol Bioscience with a free account
·The complete investor list: 14 names
·Watch Axol Bioscience: the Monday email on marks, rounds and moves
